Advertisement

Product › Details
Entresto®
![]() |
Next higher product group | sacubitril / valsartan |
![]() |
Status | 2015-07-08 registration start |
Annual sales | USD 507,000,000 (sales (2017) 2017) | |
![]() |
Organisation | Novartis AG (NYSE: NVS) |
Group | Novartis (Group) | |
Record changed: 2023-07-10 |
Advertisement

More documents for cardiovascular drug_o
- [1] Vifor Pharma AG. (11/22/21). "Press Release: Vifor Pharma to Spearhead Development of Vascular Calcification Field, through Acquisition of Sanifit Therapeutics and Inositec AG". St. Gallen, Palma & Zurich....
- [2] Novartis AG. (1/6/20). "Press Release: Novartis Successfully Completes Acquisition of The Medicines Company, Adding a Potentially First-in-Class, Investigational Cholesterol-lowering Therapy Inclisiran". Basel....
- [3] Novartis AG. (1/6/20). "Press Release: Novartis Completes Tender Offer for All Outstanding Shares of The Medicines Company". Basel....
- [4] Novartis AG. (11/24/19). "Press Release: Novartis to Acquire The Medicines Company for USD 9.7 bn". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top